Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Tsunoda

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
Internal Medicine (Tokyo, Japan)|July 17, 2020
Ceftriaxone-associated Pseudolithiasis in the Gallbladder and Bile Duct of an Elderly PatientAkane Yamabe, Atsushi Irisawa, Hiroto Wakabayashi, et al.
In Vivo (Athens, Greece)|April 30, 2024
Methionine Dependence of Hair Maintenance in C57BL/6 MiceYutaro Kubota, Nundini Varshney, Keita Kobayashi, et al.
In Vivo (Athens, Greece)|August 31, 2023
Rapid Reduction of CEA and Stable Metastasis in an <i>NRAS</i>-mutant Rectal-Cancer Patient Treated With FOLFIRI and Bevacizumab Combined With Oral Recombinant Methioninase and a Low-Methionine Diet Upon Metastatic Recurrence After FOLFIRI and Bevacizumab Treatment AloneYutaro Kubota, Qinghong Han, Sei Morinaga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1Hidenobu Ishizaki, Takuya Tsunoda, Satoshi Wada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Ring finger protein 43 as a new target for cancer immunotherapyNaotaka Uchida, Takuya Tsunoda, Satoshi Wada, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|December 15, 2025
A case of celiac disease carrying the half DQ2 variant with a variety of psychiatric manifestationsAkiko Sato, Yasuto Kunii, Takuya Tsunoda, et al.
Frontiers in Immunology|December 20, 2023
Corrigendum: Soluble PD-L1 changes in advanced non-small cell lung cancer patients treated with PD-1 inhibitors: an individual patient data meta-analysisTakashi Shimizu, Eisuke Inoue, Ryotaro Ohkuma, et al.
Current Pharmaceutical Biotechnology|February 21, 2012
Recent advances in active specific cancer vaccine treatment for colorectal cancerKiyotaka Okuno, Fumiaki Sugiura, Kyogo Itoh, et al.
Cancer Immunology, Immunotherapy : CII|December 14, 2004
Dendritic cells might be one of key factors for eliciting antitumor effect by chemoimmunotherapy in vivoHiroyuki Mushiake, Takuya Tsunoda, Mamoru Nukatsuka, et al.
International Journal of Oncology|July 6, 2006
Identification of TOMM34, which shows elevated expression in the majority of human colon cancers, as a novel drug targetTakashi Shimokawa, Satoshi Matsushima, Takuya Tsunoda, et al.
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
Internal Medicine (Tokyo, Japan)|July 17, 2020
Ceftriaxone-associated Pseudolithiasis in the Gallbladder and Bile Duct of an Elderly PatientAkane Yamabe, Atsushi Irisawa, Hiroto Wakabayashi, et al.
In Vivo (Athens, Greece)|April 30, 2024
Methionine Dependence of Hair Maintenance in C57BL/6 MiceYutaro Kubota, Nundini Varshney, Keita Kobayashi, et al.
In Vivo (Athens, Greece)|August 31, 2023
Rapid Reduction of CEA and Stable Metastasis in an <i>NRAS</i>-mutant Rectal-Cancer Patient Treated With FOLFIRI and Bevacizumab Combined With Oral Recombinant Methioninase and a Low-Methionine Diet Upon Metastatic Recurrence After FOLFIRI and Bevacizumab Treatment AloneYutaro Kubota, Qinghong Han, Sei Morinaga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1Hidenobu Ishizaki, Takuya Tsunoda, Satoshi Wada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Ring finger protein 43 as a new target for cancer immunotherapyNaotaka Uchida, Takuya Tsunoda, Satoshi Wada, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|December 15, 2025
A case of celiac disease carrying the half DQ2 variant with a variety of psychiatric manifestationsAkiko Sato, Yasuto Kunii, Takuya Tsunoda, et al.
Frontiers in Immunology|December 20, 2023
Corrigendum: Soluble PD-L1 changes in advanced non-small cell lung cancer patients treated with PD-1 inhibitors: an individual patient data meta-analysisTakashi Shimizu, Eisuke Inoue, Ryotaro Ohkuma, et al.
Current Pharmaceutical Biotechnology|February 21, 2012
Recent advances in active specific cancer vaccine treatment for colorectal cancerKiyotaka Okuno, Fumiaki Sugiura, Kyogo Itoh, et al.
Cancer Immunology, Immunotherapy : CII|December 14, 2004
Dendritic cells might be one of key factors for eliciting antitumor effect by chemoimmunotherapy in vivoHiroyuki Mushiake, Takuya Tsunoda, Mamoru Nukatsuka, et al.
International Journal of Oncology|July 6, 2006
Identification of TOMM34, which shows elevated expression in the majority of human colon cancers, as a novel drug targetTakashi Shimokawa, Satoshi Matsushima, Takuya Tsunoda, et al.
Pageof 13